Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits

Judith A Siuciak1, Sheryl A McCarthy, A N Martin

  • 1CNS Discovery, Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06340, USA. judith.siuciak@gmail.com

Psychopharmacology
|June 15, 2007
PubMed
Abstract

Related Concept Videos